204 related articles for article (PubMed ID: 30386138)
1. Optimal Phase of Dynamic Computed Tomography for Reliable Size Measurement of Metastatic Neuroendocrine Tumors of the Liver: Comparison between Pre- and Post-Contrast Phases.
Huh J; Park J; Kim KW; Kim HJ; Lee JS; Lee JH; Jeong YK; Shinagare AB; Ramaiya NH
Korean J Radiol; 2018; 19(6):1066-1076. PubMed ID: 30386138
[TBL] [Abstract][Full Text] [Related]
2. Liver metastases of neuroendocrine tumors: is it possible to diagnose different histologic subtypes depending on multiphasic CT features?
Gulpinar B; Peker E; Kul M; Elhan AH; Haliloglu N
Abdom Radiol (NY); 2019 Jun; 44(6):2147-2155. PubMed ID: 30863999
[TBL] [Abstract][Full Text] [Related]
3. Hypervascular liver metastases: do unenhanced and hepatic arterial phase CT images affect tumor detection?
Oliver JH; Baron RL; Federle MP; Jones BC; Sheng R
Radiology; 1997 Dec; 205(3):709-15. PubMed ID: 9393525
[TBL] [Abstract][Full Text] [Related]
4. Measurement variability of liver metastases from neuroendocrine tumors on different magnetic resonance imaging sequences.
Lestra T; Kanagaratnam L; Mulé S; Janvier A; Brixi H; Cadiot G; Dohan A; Hoeffel C
Diagn Interv Imaging; 2018 Feb; 99(2):73-81. PubMed ID: 29339222
[TBL] [Abstract][Full Text] [Related]
5. Are we reproducible in measurement of NET liver metastasis?
Moalla S; Arfi Rouche J; Foulon S; Caramella C; Ternes N; Planchard D; Goere D; Ducreux M; Scoazec JY; Deschamps F; Dromain C; Baudin E
Dig Liver Dis; 2017 Oct; 49(10):1121-1127. PubMed ID: 28844707
[TBL] [Abstract][Full Text] [Related]
6. Duodenal neuroendocrine tumors: retrospective evaluation of CT imaging features and pattern of metastatic disease on dual-phase MDCT with pathologic correlation.
Tsai SD; Kawamoto S; Wolfgang CL; Hruban RH; Fishman EK
Abdom Imaging; 2015 Jun; 40(5):1121-30. PubMed ID: 25504375
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of hepatic abscess from metastasis on contrast-enhanced dynamic computed tomography in patients with a history of extrahepatic malignancy: emphasis on dynamic change of arterial rim enhancement.
Oh JG; Choi SY; Lee MH; Lee JE; Yi BH; Kim SS; Min JH; Lee B
Abdom Radiol (NY); 2019 Feb; 44(2):529-538. PubMed ID: 30196363
[TBL] [Abstract][Full Text] [Related]
8. Is diffusion-weighted MRI sufficient for follow-up of neuroendocrine tumour liver metastases?
Lavelle LP; O'Neill AC; McMahon CJ; Cantwell CP; Heffernan EJ; Malone DE; Daly L; Skehan SJ
Clin Radiol; 2016 Sep; 71(9):863-8. PubMed ID: 27345612
[TBL] [Abstract][Full Text] [Related]
9. Detecting hepatocellular carcinoma: value of unenhanced or arterial phase CT imaging or both used in conjunction with conventional portal venous phase contrast-enhanced CT imaging.
Oliver JH; Baron RL; Federle MP; Rockette HE
AJR Am J Roentgenol; 1996 Jul; 167(1):71-7. PubMed ID: 8659425
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Magnetic Resonance (MR) Biomarkers for Assessment of Response With Response Evaluation Criteria in Solid Tumors: Comparison of the Measurements of Neuroendocrine Tumor Liver Metastases (NETLM) With Various MR Sequences and at Multiple Phases of Contrast Administration.
Luersen GF; Wei W; Tamm EP; Bhosale PR; Szklaruk J
J Comput Assist Tomogr; 2016; 40(5):717-22. PubMed ID: 27636124
[TBL] [Abstract][Full Text] [Related]
11. MR diagnosis of hepatic metastases from neuroendocrine tumors versus hemangiomas: relative merits of dynamic gadolinium chelate-enhanced gradient-recalled echo and unenhanced spin-echo images.
Soyer P; Gueye C; Somveille E; Laissy JP; Scherrer A
AJR Am J Roentgenol; 1995 Dec; 165(6):1407-13. PubMed ID: 7484575
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
[TBL] [Abstract][Full Text] [Related]
13. Dual-phase helical CT of the liver: value of an early-phase acquisition in the differential diagnosis of noncystic focal lesions.
Van Hoe L; Baert AL; Gryspeerdt S; Vandenbosh G; Nevens F; Van Steenbergen W; Marchal G
AJR Am J Roentgenol; 1997 May; 168(5):1185-92. PubMed ID: 9129409
[TBL] [Abstract][Full Text] [Related]
14. Is a single portal venous phase in contrast-enhanced CT sufficient to detect metastases or recurrence in clear cell renal cell carcinoma? - a single-center retrospective study.
Hagen F; Peisen F; Spogis J; Mair A; Nikolaou K; Stenzl A; Kruck S; Bedke J; Kaufmann S; Thaiss WM
Cancer Imaging; 2022 Jan; 22(1):9. PubMed ID: 35063030
[TBL] [Abstract][Full Text] [Related]
15. Focal liver masses: enhancement patterns on contrast-enhanced images--concordance of US scans with CT scans and MR images.
Burns PN; Wilson SR
Radiology; 2007 Jan; 242(1):162-74. PubMed ID: 17090710
[TBL] [Abstract][Full Text] [Related]
16. Detection of neuroendocrine liver metastases with MnDPDP-enhanced MRI.
Rockall AG; Planche K; Power N; Nowosinska E; Monson JP; Grossman AB; Reznek RH
Neuroendocrinology; 2009; 89(3):288-95. PubMed ID: 19023191
[TBL] [Abstract][Full Text] [Related]
17. Dual phase helical CT versus portal venous phase CT for the detection of colorectal liver metastases: correlation with intra-operative sonography, surgical and pathological findings.
Scott DJ; Guthrie JA; Arnold P; Ward J; Atchley J; Wilson D; Robinson PJ
Clin Radiol; 2001 Mar; 56(3):235-42. PubMed ID: 11247703
[TBL] [Abstract][Full Text] [Related]
18. 68Ga-DOTATOC PET/CT of neuroendocrine tumors: spotlight on the CT phases of a triple-phase protocol.
Ruf J; Schiefer J; Furth C; Kosiek O; Kropf S; Heuck F; Denecke T; Pavel M; Pascher A; Wiedenmann B; Amthauer H
J Nucl Med; 2011 May; 52(5):697-704. PubMed ID: 21498531
[TBL] [Abstract][Full Text] [Related]
19. Qualitative and quantitative image analysis of CT and MR imaging in patients with neuroendocrine liver metastases in comparison to (68)Ga-DOTATOC PET.
Flechsig P; Zechmann CM; Schreiweis J; Kratochwil C; Rath D; Schwartz LH; Schlemmer HP; Kauczor HU; Haberkorn U; Giesel FL
Eur J Radiol; 2015 Aug; 84(8):1593-1600. PubMed ID: 25999064
[TBL] [Abstract][Full Text] [Related]
20. High sensitivity of diffusion-weighted MR imaging for the detection of liver metastases from neuroendocrine tumors: comparison with T2-weighted and dynamic gadolinium-enhanced MR imaging.
d'Assignies G; Fina P; Bruno O; Vullierme MP; Tubach F; Paradis V; Sauvanet A; Ruszniewski P; Vilgrain V
Radiology; 2013 Aug; 268(2):390-9. PubMed ID: 23533288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
